Natco Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE987B01026
  • NSEID: NATCOPHARM
  • BSEID: 524816
INR
817.00
-4.5 (-0.55%)
BSENSE

Nov 20

BSE+NSE Vol: 6.23 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
967.30
735.20
739.10
647.30
1,363.00
1,328.90
1,221.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
967.30
735.20
739.10
647.30
1,363.00
1,328.90
1,221.00
Raw Material Cost
171.70
157.80
102.80
135.20
174.90
180.60
169.00
Purchase of Finished goods
81.80
27.80
37.50
55.80
72.60
37.30
40.80
(Increase) / Decrease In Stocks
-70.40
-38.10
14.40
-57.90
-77.80
15.10
39.40
Employee Cost
203.60
179.30
158.50
159.40
200.30
169.00
159.40
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
322.70
221.90
298.30
196.10
413.80
355.90
264.30
Total Expenditure (Excl Depreciation)
709.40
548.70
611.50
488.60
783.80
757.90
672.90
Operating Profit (PBDIT) excl Other Income
257.90
186.50
127.60
158.70
579.20
571.00
548.10
Other Income
52.10
59.20
77.80
58.10
100.00
61.70
66.30
Operating Profit (PBDIT)
310.00
245.70
205.40
216.80
679.20
632.70
614.40
Interest
17.60
13.00
10.90
9.50
13.10
3.20
10.20
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
292.40
232.70
194.50
207.30
666.10
629.50
604.20
Depreciation
49.20
47.10
50.40
46.20
52.40
57.60
98.30
Profit Before Tax
243.20
185.60
144.10
161.10
613.70
571.90
505.90
Tax
69.80
63.40
-89.20
20.70
95.80
91.60
99.90
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
173.40
122.20
233.30
140.40
517.90
480.30
406.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
173.40
122.20
233.30
140.40
517.90
480.30
406.00
Share in Profit of Associates
29.20
84.30
35.70
10.90
0.00
0.00
0.00
Minority Interest
0.00
0.00
1.10
-0.20
-0.50
-0.40
-0.60
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
202.60
206.50
267.90
151.50
518.40
480.70
406.60
Equity Capital
35.80
35.80
35.80
35.80
35.80
35.80
35.80
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
11.23
11.44
14.85
8.46
28.73
26.85
22.72
Diluted Earnings per share
11.22
11.44
14.84
8.46
28.71
26.84
22.7
Operating Profit Margin (Excl OI)
26.66%
25.37%
17.26%
24.52%
42.49%
42.97%
44.89%
Gross Profit Margin
30.23%
31.65%
26.32%
32.03%
48.87%
47.37%
49.48%
PAT Margin
17.93%
16.62%
31.57%
21.69%
38.0%
36.14%
33.25%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is 31.57% vs -0.53% in Jun 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2026 is -1.89% vs -22.92% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is 38.28% vs 46.16% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is 35.38% vs 19.27% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

Compare Quarterly Results Of Natco Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
967.30
476.65
490.65
102.94%
Other Operating Income
0.00
0.00
0.00
Total Operating income
967.30
476.65
490.65
102.94%
Raw Material Cost
171.70
236.64
-64.94
-27.44%
Purchase of Finished goods
81.80
0.00
81.80
(Increase) / Decrease In Stocks
-70.40
-97.55
27.15
27.83%
Employee Cost
203.60
153.54
50.06
32.60%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
322.70
148.64
174.06
117.10%
Total Expenditure (Excl Depreciation)
709.40
441.27
268.13
60.76%
Operating Profit (PBDIT) excl Other Income
257.90
35.38
222.52
628.94%
Other Income
52.10
12.41
39.69
319.82%
Operating Profit (PBDIT)
310.00
47.79
262.21
548.67%
Interest
17.60
8.37
9.23
110.27%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
292.40
39.42
252.98
641.76%
Depreciation
49.20
50.17
-0.97
-1.93%
Profit Before Tax
243.20
-10.75
253.95
2,362.33%
Tax
69.80
-13.02
82.82
636.10%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
173.40
2.27
171.13
7,538.77%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
173.40
2.27
171.13
7,538.77%
Share in Profit of Associates
29.20
0.00
29.20
Minority Interest
0.00
-12.95
12.95
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
202.60
15.22
187.38
1,231.14%
Equity Capital
35.80
38.26
-2.46
-6.43%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
11.23
0.40
10.83
2,707.50%
Diluted Earnings per share
11.22
0.38
10.84
2,852.63%
Operating Profit Margin (Excl OI)
26.66%
7.42%
0.00
19.24%
Gross Profit Margin
30.23%
8.27%
0.00
21.96%
PAT Margin
17.93%
0.48%
0.00
17.45%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 967.30 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 31.57% vs -0.53% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -29.03% vs -0.59% in Sep 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 202.60 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -1.89% vs -22.92% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -60.92% vs -23.46% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 257.90 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 38.28% vs 46.16% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -55.47% vs -27.99% in Sep 2025

Quarterly - Interest
Interest 17.60 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 35.38% vs 19.27% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 34.35% vs 219.51% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.66%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025